Sex: U
Vaccine: DTAP, DTAPIPV, DTAPIPVHIB, FLU4, FLU4, HIBV, MNQ, TD, TDAP, UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: Exposed to temperature excursions at temperature range of =0°C for =72 hours with no reported adverse event; Initial information received on 31-Jan-202 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a patient with unknown demographics who was exposed to temperature excursions at temperature range of =0°c for =72 hours with no reported adverse event while receiving vaccines [PENTACEL],[QUADRACEL],[TENIVAC],[MENACTRA],[FLUZONE QUADRIVALENT],[FLUZONE HIGH-DOSE QUADRIVALENT],[ActHIB],[DAPTACEL] and [ADACEL] and while treated with [TUBERSOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient started taking TUBERSOL (TUBERCULIN TEST) Solution for injection dosage unknown (with an unknown batch number).  On an unknown date, the patient received a  dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot number not reported via unknown route in unknown administration site. On an unknown date, the patient received a  dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient received a  dose of suspect HIB (PRP/T) VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient received a  dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient received a  dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient received a  dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient received a  dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient received a  dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient received a  dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date the patient was exposed to temperature excursions at temperature range of =0°c for =72 hours with no reported adverse event (intercepted product storage error) (unknown latency)following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (Exposed to temperature excursions at temperature range of =0°C for =72 hours with no reported adverse event).  At time of reporting, the outcome was Unknown for the event exposed to temperature excursions at temperature range of =0°c for =72 hours with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.